When administered under medical supervision, B12 injections are well-tolerated, safe, and have minimal risk of side effects
[15] Lipoic acid serves as co-factor to the acetoin dehydrogenase complex catalyzing the conversion of acetoin (3-hydroxy-2-butanone) to acetaldehyde and acetyl coenzyme A
In addition, immune and allergic reactions to non-human enzymes can compromise therapy and harm patients
These injectable therapies, often administered once weekly, provide sustained, controlled release, ensuring steady therapeutic effects with minimal intervention
But Medicare covers GLP-1 medications only to treat Type 2 diabetes and for cardiovascular disease that may be worsened by a patient's excess weight
This is considered the optimal dose for beneficial results and manageable side effects